Similarities between CYP3A4 and Neratinib
CYP3A4 and Neratinib have 4 things in common (in Unionpedia): H2 antagonist, Hepatotoxicity, Proton-pump inhibitor, Temsirolimus.
H2 antagonist
H2 antagonists, sometimes referred to as H2RA and also called H2 blockers, are a class of medications that block the action of histamine at the histamine H2 receptors of the parietal cells in the stomach.
CYP3A4 and H2 antagonist · H2 antagonist and Neratinib ·
Hepatotoxicity
Hepatotoxicity (from hepatic toxicity) implies chemical-driven liver damage.
CYP3A4 and Hepatotoxicity · Hepatotoxicity and Neratinib ·
Proton-pump inhibitor
Proton-pump inhibitors (PPIs) are a group of drugs whose main action is a pronounced and long-lasting reduction of stomach acid production.
CYP3A4 and Proton-pump inhibitor · Neratinib and Proton-pump inhibitor ·
Temsirolimus
Temsirolimus (codenamed CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007.
The list above answers the following questions
- What CYP3A4 and Neratinib have in common
- What are the similarities between CYP3A4 and Neratinib
CYP3A4 and Neratinib Comparison
CYP3A4 has 307 relations, while Neratinib has 25. As they have in common 4, the Jaccard index is 1.20% = 4 / (307 + 25).
References
This article shows the relationship between CYP3A4 and Neratinib. To access each article from which the information was extracted, please visit: